LUNGevity lung cancer translational research award programs in 2021

Organization
LUNGevity Foundation
Type
Foundation
Application Due Date
02-24-2021
Comments
LOI required and due 2/24/21; Full application due (by invitation only): May 10, 2021, 11:59 pm EDT
Brief Description

LUNGevity Foundation is pleased to offer five lung cancer translational research award programs in 2021:

  • LUNGevity’s Career Development Award Program was created to support future research leaders who will keep the field of lung cancer research vibrant with new ideas. Research that will be funded in 2021 is expected to have a direct impact on the early detection of lung cancer and/or individualized lung cancer treatment, including through targeted therapy and immunotherapy.
    Learn more
  • LUNGevity’s Early Detection Award Program supports the development of strategies for the early detection and/or diagnosis of lung cancer. Research that will be funded in 2021 is expected to have a direct impact on the early detection and/or diagnosis of lung cancer or to provide a clear conceptual or experimental foundation for the future development of methods for early detection and/or diagnosis of lung cancer.
    Learn more
  • LUNGevity’s Veterans Affairs Research Scholar Award Program supports fellows or junior faculty interested in lung cancer research within the Department of Veterans Affairs. Projects that will be funded in 2021 are expected to have a direct impact on the early detection of lung cancer or on the outcomes of lung cancer, or to provide a clear conceptual or experimental foundation for the future development of methods for early detection and/or individualized treatment. In addition, the proposed research must have relevance to the veteran population, related to either screening/early detection of lung cancer or treatment. This is a mentored award.
    Learn more
  • LUNGevity’s Health Equity and Inclusiveness Junior Investigator Award Program supports physician-scientists interested in conducting lung cancer clinical research and bridging health disparities by engaging underserved communities or underrepresented minorities. Projects that will be funded in 2021 are expected to have a direct impact on the early detection of lung cancer or on the outcomes of lung cancer, or to provide a clear conceptual or experimental foundation for the future development of methods for early detection and/or individualized treatment.
    Learn more
  • LUNGevity’s Health Equity and Inclusiveness Research Fellow Award Program supports fellows interested in translational lung cancer research who belong to underrepresented minorities in STEM. Projects that will be funded in 2021 are expected to have a direct impact on the early detection of lung cancer or on the outcomes of lung cancer, or to provide a clear conceptual or experimental foundation for the future development of methods for early detection and/or individualized treatment. This is a mentored award.
    Learn more